Objective: To evaluate lung disease progression using airway and artery (AA)
dimensions on chest CT over 2-year interval in young CF patients longitudinally and
compare to disease controls cross-sectionally.
Methods: Retrospective analysis of pressure controlled end-inspiratory CTs, 12
routine baseline (CT1) and follow up (CT2) from AREST CF cohort; 12 disease controls with normal CT. All visible AA-pairs were measured perpendicular to the airway axis. Inner and outer airway diameters and wall (outer-inner radius) thickness were divided by adjacent arteries to compute AinA-, AoutA-, and AWTA-ratios, respectively. Differences between CF and control data were assessed using mixed effects models predicting AA-ratios per segmental generation (SG). Power calculations were performed with 80% power and ɑ = 0.05.
Results: CF, median age CT1 2 years; CT2 3.9 years, 5 males. Controls, median age 2.9 years, 10 males. Total of 4798 AA-pairs measured. Cross-sectionally: AinA-ratio
showed no difference between controls and CF CT1 or CT2. AoutA-ratio was
significantly higher in CF CT1 (SG 2-4) and CT2 (SG 2-5) compared to controls. AWTAratio was increased for CF CT1 (SG 1-5) and CT2 (SG 2-6) compared to controls. CF longitudinally: AinA-ratio was significantly higher at CT2 compared to CT1. Increase in AoutA-ratio at CT2 compared to CT1 was visible in SG ≥4. Sample sizes of 21 and 58 would be necessary for 50%and 30%AoutA-ratio reductions, respectively, between CF CT2 and controls.
Conclusion: AA-ratio differences were present in young CF patients relative to disease controls. AoutA-ratio as an objective parameter for bronchiectasis could reduce sample sizes for clinical trials.
Authors: Wieying Kuo, Thomas Soffers, Eleni-Rosalina Andrinopoulou, Tim Rosenow, Sarath Ranganathan, Lidija Turkovic, Stephen M. Stick, Harm A.W.M. Tiddens on behalf of AREST CF.
Published in Pediatric Pulmonology in September 2017.